How This Actually Works, Step by Step

The process is not mysterious. It is a sequence of document preparation, clinical review, and structured feedback. Here is the real flow.

Step 1: You compile what you already have. Most patients assume they need to travel with original films. You do not. What matters is a complete digital record: recent imaging reports, pathology slides or scanned biopsy reports, genetic testing results if available, current medication list, and a concise clinical summary from your treating physician. Missing pieces slow everything down.

Step 2: We review the file for completeness. A coordinator checks that the imaging is readable, the reports are in English or can be translated, and that no critical lab value is missing. This step prevents the most common failure: sending a file that a Chinese specialist cannot interpret.

Step 3: The records go to a relevant specialty team. This is where hospital selection matters. A rare neurological condition goes to a different department than a rare hematological one. We match the case to the appropriate department at a Fudan-ranked or JCI-accredited hospital, often in Beijing or Shanghai.

Step 4: The specialist reviews and writes an analysis. You receive a written document in English. It typically includes a diagnostic impression, an assessment of your current treatment plan, and suggestions for further testing or therapeutic direction. For a written second opinion, expect $300–500. For a video consultation where you speak directly with the specialist, expect $100–300 for a standard international department or $500–800 for a top specialist.

Step 5: You decide what to do next. Some patients use the review to advocate for changes with their home doctor. Others proceed to in-person treatment in China. The written opinion is not a prescription. It is a clinical reference document.

What “Sending Your Records” Actually Means for a Rare Disease

Rare disease reviews are different from standard second opinions. A typical oncology review evaluates a known cancer against standard protocols. A rare disease review often starts with a diagnostic question: is this diagnosis even correct? That changes what you send.

You need to send MRI and biopsy results to China for review in a format that allows a specialist to re-examine the raw data, not just the summary. For imaging, that means DICOM files on a CD or secure upload link, not JPEG screenshots. For pathology, it means the full pathology report plus, ideally, digital slide images. If your diagnosis hinges on a genetic variant, include the full variant report with the laboratory name and sequencing method. A one-line summary saying “positive for mutation X” is not enough.

Hospitals in Shanghai have particular strength here. If you are researching the best rare disease specialist hospital Shanghai has to offer, look at institutions with dedicated rare disease centers and high case volumes. Zhongshan Hospital Fudan University and Ruijin Hospital both maintain substantial rare disease programs. Our specialty department rankings can help you see which hospital leads in your specific category.

And if you are asking can I get a remote consultation for rare disease in Beijing, the answer is yes. Peking Union Medical College Hospital runs one of the most comprehensive rare disease networks in the country. Remote video consultations are routinely arranged through their international department. You do not need to be in Beijing to start.

A Realistic Timeline

People underestimate the waiting steps. Here is what a typical international patient medical records transfer China rare disease timeline looks like.

The total for a remote review alone is usually four to six weeks. If you proceed to in-person treatment, add another one to two months for visa processing and hospital scheduling. Anyone promising a complete review in three days is not being honest about how Chinese hospital international departments work.

What Can Go Wrong — and What Happens Then

Three failures dominate.

Incomplete imaging. You send a CD with a viewer you used at home. The hospital in China cannot open the proprietary software. Fix: request DICOM format explicitly from your imaging center. If you cannot get DICOM, ask us to coordinate a secure upload portal that accepts standard formats.

Language gaps in pathology reports. Your biopsy was done in a language other than English. A raw machine translation mangles medical terminology. Fix: we use medical translators, not generic translation tools. This adds a few days but prevents dangerous misinterpretation.

Wrong specialty match. A rare vascular condition gets sent to a general cardiologist when it needs a vascular anomalies specialist. The review comes back shallow. Fix: we confirm the sub-specialty before submission. If the first match is wrong, we re-route the file. That is part of the coordination service, not an extra charge.

How to Evaluate Whether a Chinese Review Is Worth It

Not every rare disease case benefits equally from a Chinese second opinion. The value is highest in three situations.

First, when the disease has a known genetic basis and Chinese centers have published large case series. Second, when a surgical intervention is being considered and you want to compare surgical volume and technique. Third, when your local system has given you conflicting diagnoses and you need a fresh, high-volume perspective.

The value is lower when your case is already well-managed under an established international protocol and no new intervention is being considered. In that scenario, a written opinion may confirm what you already know. That is still useful, but you should be clear-eyed about what you are paying for.

On cost: a written second opinion in the United States at a major academic center often runs $1,000–3,000. In China, the same review through a top hospital international department typically costs $300–500. A video consultation with a leading specialist runs $500–800. The rare disease second opinion China cost advantage is real, but it comes with coordination complexity. That is the trade-off.

Practical Considerations: Records, Visas, Payment, and Follow-Up

Records format. DICOM for imaging. Full text reports for pathology. VCF or PDF for genetic variants. A one-page clinical summary written by you or your doctor. Do not send original films by mail unless explicitly requested.

Visa. If you later travel to China for in-person evaluation or treatment, you apply for an S2 visa with a medical treatment annotation. Accompanying family members also use S2. The M visa is for commercial trade and has no role in medical travel. Processing times vary by embassy, so plan six to eight weeks ahead.

Payment. Remote consultation fees are paid in advance through the hospital’s international department or our coordination service. Public hospitals in China generally require pre-payment for services; private international hospitals may bill your insurer directly. Reimbursement from your home insurer depends on your policy. Request an itemized receipt.

Follow-up at home. The written opinion is yours to keep. Share it with your primary specialist. If the Chinese team recommends a specific test not available locally, ask whether the test can be done in China during a future visit or whether a sample can be sent. Some genetic panels are only available in-country.

Frequently Asked Questions